Listed

F5, Inc.: Form 10-Q for the period ended Dec 31, 2020

Filed with the SEC on Feb 5, 2021 and accepted by EDGAR at Feb 5, 2021, 16:46 ET.

Share

Management's discussion and analysis

As filed, 27,441 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion of our financial condition and results of operations contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. These statements include, but are not limited to, statements about our plans, objectives, expectations, strategies, intentions or other characterizations of future events or circumstances and are generally identified by the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions. These forward-looking statements are based on current information and expectations and are subject to a number of risks and uncertainties. Our actual results could differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in Part II, Item 1A. "Risk Factors" herein and in other documents we file from time to time with the Securities and Exchange Commission. We assume no obligation to revise or update any such forward-looking statements.

Overview

F5 is a leading provider of multi-cloud application services which enable our customers to develop, deploy, operate, secure, and govern applications in any architecture, from on-premises to the public cloud. Our enterprise-grade application services are available as cloud-based, software-as-a-service, and software-only solutions optimized for multi-cloud environments, with modules that can run independently, or as part of an integrated solution on our high-performance appliances. We market and sell our products primarily through multiple indirect sales channels in the Americas (primarily the United States); Europe, the Middle East, and Africa (EMEA); and the Asia Pacific region (APAC). Enterprise customers (Fortune 1000 or Business Week Global 1000 companies) in the technology, telecommunications, financial services, transportation, education, manufacturing and health care industries, along with government customers, continue to make up the largest percentage of our customer base.

Our management team monitors and analyzes a number of key performance indicators in order to manage our business and evaluate our financial and operating performance on a consolidated basis. Those indicators include:

  • Revenues. The majority of our revenues are derived from sales of our application delivery controller (ADC) products including our BIG-IP appliances and VIPRION chassis and related software modules and our software-only Virtual Editions; Local Traffic Manager (LTM), DNS Services (formerly Global Traffic Manager); Advanced Firewall Manager (AFM) and Policy Enforcement Manager (PEM), that leverage the unique performance characteristics of our hardware and software architecture; and products that incorporate acquired technology, including Application Security Manager (ASM) and Access Policy Manager (APM); NGINX Plus and NGINX Controller; Shape Defense and Enterprise Defense; and the Secure Web Gateway and Silverline DDoS and Application security offerings which are sold to customers on a subscription basis. We also derive revenues from the sales of services including annual maintenance contracts, training and consulting services. We carefully monitor the sales mix of our revenues within each reporting period. We believe customer acceptance rates of our new products and feature enhancements are indicators of future trends. We also consider overall revenue concentration by customer and by geographic region as additional indicators of current and future trends. We are also monitoring the uncertainty related to the impacts that the COVID-19 pandemic has on the global economy and our customer base.
  • Cost of revenues and gross margins. We strive to control our cost of revenues and thereby maintain our gross margins. Significant items impacting cost of revenues are hardware costs paid to our contract manufacturers, third-party software license fees, software-as-a-service infrastructure costs, amortization of developed technology and personnel and overhead expenses. Our margins have remained relatively stable; however, factors such as sales price, product and services mix, inventory obsolescence, returns, component price increases, warranty costs, and the uncertainty surrounding the COVID-19 pandemic and its potential impacts to our supply chain could significantly impact our gross margins from quarter to quarter and represent significant indicators we monitor on a regular basis.
  • Operating expenses. Operating expenses are substantially driven by personnel and related overhead expenses. Existing headcount and future hiring plans are the predominant factors in analyzing and forecasting future operating expense trends. Other significant operating expenses that we monitor include marketing and promotions, travel, professional fees, computer costs related to the development of new products and provision of services, facilities and depreciation expenses.
  • Liquidity and cash flows. Our financial condition remains strong with significant cash and investments. The increase in cash and investments for the first three months of fiscal year 2021 was primarily due to cash provided by operating activities of $137.4 million. Going forward, we believe the primary driver of cash flows will be net income from operations. Capital expenditures of $4.7 million for the first three months of fiscal year 2021 were primarily related to the expansion of our facilities to support our operations worldwide as well as investments in information technology infrastructure and equipment purchases to support our core business activities. We will continue to evaluate possible

acquisitions of, or investments in businesses, products, or technologies that we believe are strategic, which may require the use of cash. Additionally, on January 31, 2020, we entered into a Revolving Credit Agreement (the "Revolving Credit Agreement") that provides for a senior unsecured revolving credit facility in an aggregate principal amount of $350.0 million (the "Revolving Credit Facility"). We have the option to increase commitments under the Revolving Credit Facility from time to time, subject to certain conditions, by up to $150.0 million. As of December 31, 2020, there were no outstanding borrowings under the Revolving Credit Facility, and we had available borrowing capacity of $350.0 million.

  • Balance sheet. We view cash, short-term and long-term investments, deferred revenue, accounts receivable balances and days sales outstanding as important indicators of our financial health. Deferred revenues continued to increase in the first quarter of fiscal year 2021 due to the growth of our subscriptions business, including the acquired deferred revenue associated with the Shape acquisition. Our days sales outstanding for the first quarter of fiscal year 2021 was 50. Days sales outstanding is calculated by dividing ending accounts receivable by revenue per day for a given quarter.

Summary of Critical Accounting Policies and Estimates

The preparation of our financial condition and results of operations requires us to make judgments and estimates that may have a significant impact upon our financial results. We believe that, of our significant accounting policies, the following require estimates and assumptions that require complex, subjective judgments by management, which can materially impact reported results: revenue recognition, accounting for business combinations and accounting for leases. Actual results may differ from these estimates under different assumptions or conditions.

There were no material changes to our critical accounting policies and estimates compared to the critical accounting policies and estimates described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Form 10-K for the fiscal year ended September 30, 2020. Refer to the "Recently Adopted Accounting Standards" section of Note 1 in this Quarterly Report on Form 10-Q for a summary of the new accounting policies.

COVID-19 Update

Management has prioritized a human-first approach to the COVID-19 pandemic. For F5, this means ensuring the health and safety of employees, their families and our communities. Further, this approach extends to our customers as we look for ways that we can support their operations during this crisis.

While our analysis shows COVID-19 did not have a significant impact on our results of operations for the quarter ended December 31, 2020, the impacts of the global pandemic on our business and financial outlook are currently unknown. We are conducting business with substantial modifications to employee travel, employee work locations, and virtualization or cancellation of certain sales and marketing events, among other modifications. We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state or local authorities, or that we determine are in the best interests of our employees, customers, partners, suppliers and stockholders. It is not clear what the potential effects any such alterations or modifications may have on our business, including the effects on our customers and prospects, or on our financial results.

Results of Operations

The following discussion and analysis should be read in conjunction with our consolidated financial statements, related notes and risk factors included elsewhere in this Quarterly Report on Form 10-Q.

(in thousands, except percentages)

Net revenues Three months ended December 31, 2020 2019
Products $288,045 $234,536
Services 336,572 334,769
Total $624,617 $569,305
Percentage of net revenues
Products 46.1% 41.2%
Services 53.9 58.8
Total 100.0% 100.0%

25

Net Revenues. Total net revenues increased 9.7% for the three months ended December 31, 2020, from the comparable period in the prior year. Overall revenue growth for the three months ended December 31, 2020, was primarily due to the addition of the software-as-a-service product offerings through the Shape acquisition and our subscription-based offerings, which include our enterprise license agreement product offerings. Revenues outside of the United States represented 48.7% of total net revenues for the three months ended December 31, 2020, compared to 51.6% for the same period in the prior year.

Net Product Revenues. Net product revenues increased 22.8% for the three months ended December 31, 2020, from the comparable period in the prior year. The increase of $53.5 million in net product revenues for the three months ended December 31, 2020 was primarily due to an increase in software sales compared to the same period in the prior year.

The following presents net product revenues by systems and software (in thousands):

Net product revenues Three months ended December 31, 2020 2019
Systems revenue $178,571 $169,601
Software revenue 109,474 64,935
Total net product revenue $288,045 $234,536
Percentage of net product revenues
Systems revenue 62.0% 72.3%
Software revenue 38.0 27.7
Total net product revenue 100.0% 100.0%

Net Service Revenues. Net service revenues of $336.6 million remained relatively flat for the three months ended December 31, 2020, from the comparable period in the prior year.

The following distributors of our products accounted for more than 10% of total net revenue:

Three months ended December 31, 2020 2019
Ingram Micro, Inc. 18.1% 16.5%
Westcon Group, Inc. — 11.0%
Arrow ECS — 10.1%
Synnex Corporation 10.0% —

The following distributors of our products accounted for more than 10% of total receivables:

December 31, 2020 September 30, 2020
Ingram Micro, Inc. 14.6% 14.1%
Arrow ECS 15.6% —
Synnex Corporation 13.6% 11.4%

No other distributors accounted for more than 10% of total net revenue or receivables.

(in thousands, except percentages)

Cost of net revenues and gross profit Three months ended December 31, 2020 2019
Products $67,038 $42,118
Services 47,941 46,524
Total 114,979 88,642
Gross profit $509,638 $480,663
Percentage of net revenues and gross margin (as a percentage of related net revenue)
Products 23.3% 18.0%
Services 14.2 13.9
Total 18.4 15.6
Gross margin 81.6% 84.4%

Cost of Net Product Revenues. Cost of net product revenues consist of finished products purchased from our contract manufacturers, manufacturing overhead, freight, warranty, provisions for excess and obsolete inventory, software-as-a-service infrastructure costs and amortization expenses in connection with developed technology from acquisitions. Cost of net product revenues increased $24.9 million, or 59.2% for the three months ended December 31, 2020, from the comparable period in the prior year. The increase in cost of net product revenues was primarily due to an increase in revenue and related managed service costs from the Shape acquisition.

Cost of Net Service Revenues. Cost of net service revenues consist of the salaries and related benefits of our professional services staff, travel, facilities and depreciation expenses. For the three months ended December 31, 2020, cost of net service revenues as a percentage of net service revenues was 14.2%, compared to 13.9% for the comparable period in the prior year. Professional services headcount at the end of December 2020 increased to 967 from 921 at the end of December 2019.

(in thousands, except percentages)

Operating expenses Three months ended December 31, 2020 2019
Sales and marketing $214,546 $195,519
Research and development 114,191 96,005
General and administrative 63,153 59,004
Restructuring charges — 7,800
Total $391,890 $358,328
Operating expenses (as a percentage of net revenue)
Sales and marketing 34.3% 34.3%
Research and development 18.3 16.9
General and administrative 10.1 10.4
Restructuring charges — 1.4
Total 62.7% 63.0%

Sales and Marketing. Sales and marketing expenses consist of salaries, commissions and related benefits of our sales and marketing staff, the costs of our marketing programs, including public relations, advertising and trade shows, travel, facilities, and depreciation expenses. Sales and marketing expenses increased $19.0 million, or 9.7% for the three months ended December 31, 2020, from the comparable period in the prior year. The increase in sales and marketing expense was primarily due to an increase of $15.9 million in personnel costs for the three months ended December 31, 2020, from the comparable period in the prior year. Sales and marketing expenses for the three months ended December 31, 2020 also included an increase in commissions of $5.4 million from the comparable period in the prior year. The increase in sales and marketing expenses for the three months ended December 31, 2020 was partially offset by a decrease in travel and entertainment expenses primarily due to company-wide travel restrictions as a result of the COVID-19 pandemic. Sales and marketing headcount at the end of December 2020 increased to 2,398 from 2,123 at the end of December 2019. Sales and marketing expenses included stock-based compensation expense of $25.2 million for the three months ended December 31, 2020, compared to $21.8 million for the same period in the prior year.

Research and Development. Research and development expenses consist of the salaries and related benefits of our product development personnel, prototype materials and other expenses related to the development of new and improved products, facilities and depreciation expenses. Research and development expenses increased $18.2 million, or 18.9% for the three months ended December 31, 2020, from the comparable period in the prior year. The increase in research and development expense was primarily due to an increase of $9.9 million in personnel costs for the three months ended December 31, 2020, from the comparable period in the prior year. Research and development headcount at the end of December 2020 increased to 1,801 from 1,534 at the end of December 2019. Research and development expenses included stock-based compensation expense of $15.0 million for the three months ended December 31, 2020, compared to $11.2 million for the same period in the prior year.

General and Administrative. General and administrative expenses consist of the salaries, benefits and related costs of our executive, finance, information technology, human resource and legal personnel, third-party professional service fees, facilities and depreciation expenses. General and administrative expenses increased $4.1 million, or 7.0% for the three months ended December 31, 2020, from the comparable period in the prior year. For the three months ended December 31, 2020, personnel costs increased $2.7 million, from the comparable period in the prior year due to growth in general and administrative headcount, including employees from the acquisition of Shape. General and administrative headcount at the end of December 2020 increased to 735 from 616 at the end of December 2019. General and administrative expenses included stock-based compensation expense of $10.5 million for the three months ended December 31, 2020, compared to $9.2 million for the same period in the prior year.

Restructuring Charges. In the first fiscal quarter of 2020, we completed a restructuring plan to align strategic and financial objectives and optimize resources for long term growth. As a result of these initiatives, we recorded a restructuring charge of $7.8 million related to a reduction in workforce that is reflected in our results for the three months ended December 2019. There were no restructuring expenses recorded for the three months ended December 31, 2020.

(in thousands, except percentages)

Other income and income taxes Three months ended December 31, 2020 2019
Income from operations $117,748 $122,335
Other (loss) income, net (683) 5,220
Income before income taxes 117,065 127,555
Provision for income taxes 29,387 29,028
Net income $87,678 $98,527
Other income and income taxes (as percentage of net revenue)
Income from operations 18.9% 21.5%
Other (loss) income, net (0.1) 0.9
Income before income taxes 18.7 22.4
Provision for income taxes 4.7 5.1
Net income 14.0% 17.3%

Other (Loss) Income, Net. Other (loss) income, net consists primarily of interest income and expense and foreign currency transaction gains and losses. The decrease in other (loss) income, net for the three months ended December 31, 2020 was primarily due to a decrease in interest income of $4.4 million, from our investments compared to the same period in the prior year. In addition, interest expense increased $1.7 million for the three months ended December 31, 2020 compared to the same period in the prior year due to interest paid for outstanding amounts under our Term Loan Facility.

Provision for income taxes. The effective tax rate was 25.1% and 22.8% for the three months ended December 31, 2020 and 2019, respectively. The increase in the effective tax rate for the three months ended December 31, 2020 as compared to the three months ended December 31, 2019 is primarily due to the tax impact from stock-based compensation and other non-deductible expenses.

We record a valuation allowance to reduce our deferred tax assets to the amount we believe is more likely than not to be realized. In making these determinations we consider historical and projected taxable income, and ongoing prudent and feasible tax planning strategies in assessing the appropriateness of a valuation allowance. Our net deferred tax assets at December 31, 2020 and September 30, 2020 were $45.3 million and $44.6 million, respectively. The net deferred tax assets include valuation allowances of $32.9 million and $32.6 million as of December 31, 2020 and September 30, 2020, respectively, which are primarily related to certain state and foreign net operating losses and tax credit carryforwards.

Our worldwide effective tax rate may fluctuate based on a number of factors, including variations in projected taxable income in the various geographic locations in which we operate, changes in the valuation of our net deferred tax assets, resolution of potential exposures, tax positions taken on tax returns filed in the various geographic locations in which we operate, and the introduction of new accounting standards or changes in tax laws or interpretations thereof in the various geographic locations in which we operate. We have recorded liabilities to address potential tax exposures related to business and income tax positions we have taken that could be challenged by taxing authorities. The ultimate resolution of these potential exposures may be greater or less than the liabilities recorded which could result in an adjustment to our future tax expense.

Liquidity and Capital Resources

Cash and cash equivalents, short-term investments and long-term investments totaled $1,462.1 million as of December 31, 2020, compared to $1,312.8 million as of September 30, 2020, representing an increase of $149.3 million. The increase was primarily due to cash provided by operating activities of $137.4 million for the three months ended December 31, 2020. Cash provided by operating activities for the first three months of fiscal year 2021 resulted from net income of $87.7 million combined with changes in operating assets and liabilities, as adjusted for various non-cash items including stock-based compensation, deferred revenue, depreciation and amortization charges. Additionally, the increase is due to $27.2 million of cash received from the exercise of employee stock options and stock purchases under our employee stock purchase plan for the three months ended December 31, 2020.

Cash from operations could be affected by various risks and uncertainties, including, but not limited to, the effects of the COVID-19 pandemic and other risks detailed in Part II, Item 1A titled “Risk Factors”. However, we anticipate our current cash, cash equivalents and investment balances, anticipated cash flows generated from operations, and available borrowing capacity on the Revolver Credit Facility will be sufficient to meet our liquidity needs.

Cash provided by investing activities was $20.6 million for the three months ended December 31, 2020, compared to cash used in investing activities of $29.4 million for the same period in the prior year. Investing activities include purchases, sales and maturities of available-for-sale securities, business acquisitions and capital expenditures. The amount of cash provided by investing activities for the three months ended December 31, 2020 was primarily the result of $69.4 million in maturities of investments, partially offset by $42.8 million of purchases of investments and $4.7 million of capital expenditures.

Cash provided by financing activities was $17.7 million for the three months ended December 31, 2020, compared to $21.0 million for the same period in the prior year. Our financing activities for the three months ended December 31, 2020 primarily consisted of $27.2 million of cash received from the exercise of employee stock options and stock purchases under our employee stock purchase plan, partially offset by $5.0 million in cash used to make a principal payment on our term loan and $4.5 million in cash used for taxes related to net share settlement of equity awards.

On January 31, 2020, we entered into a Revolving Credit Agreement (the "Revolving Credit Agreement") that provides for a senior unsecured revolving credit facility in an aggregate principal amount of $350.0 million (the "Revolving Credit Facility"). We have the option to increase commitments under the Revolving Credit Facility from time to time, subject to certain conditions, by up to $150.0 million. As of December 31, 2020, there were no outstanding borrowings under the Revolving Credit Facility, and we had available borrowing capacity of $350.0 million.

On February 3, 2021, we entered into Accelerated Share Repurchase ("ASR") agreements with two financial institutions under which we paid an aggregate of $500 million. See Note 14, Subsequent Events, for additional information on the ASR program.

Obligations and Commitments

As of December 31, 2020, our principal commitments consisted of borrowings under the Term Loan Facility and obligations outstanding under operating leases.

In connection with the acquisition of Shape, on January 24, 2020, we entered into a Term Credit Agreement ("Term Credit Agreement") with certain institutional lenders that provides for a senior unsecured term loan facility in an aggregate principal amount of $400.0 million (the "Term Loan Facility"). The proceeds from the Term Loan Facility were primarily used to finance the acquisition of Shape and related expenses. As of December 31, 2020, $385.0 million of principal amount under the Term Loan Facility was outstanding. There is a financial covenant that requires us to maintain a leverage ratio, calculated as of the last day of each fiscal quarter, of consolidated total indebtedness to consolidated EBITDA. This covenant may result in a higher interest rate on our outstanding principal borrowings on the Term Loan Facility in future periods, depending on the Company's performance. We will monitor the effect that the COVID-19 pandemic may have on our leverage ratio calculation but do not believe there will be a material impact to the interest payable on our borrowings under the Term Loan Facility. Refer to Note 7 for the scheduled principal maturities of the Term Loan Facility as of December 31, 2020.

We lease our facilities under operating leases that expire at various dates through 2033. There have been no material changes in our principal lease commitments compared to those discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020.

We outsource the manufacturing of our pre-configured hardware platforms to contract manufacturers who assemble each product to our specifications. Our agreement with our largest contract manufacturer allows them to procure component inventory on our behalf based upon a rolling production forecast. We are contractually obligated to purchase the component inventory in accordance with the forecast, unless we give notice of order cancellation in advance of applicable lead times.

Recent Accounting Pronouncements

The anticipated impact of recent accounting pronouncements is discussed in Note 1 to the accompanying Notes to Consolidated Financial Statements of this Quarterly Report on Form 10-Q.

Market risk

As filed, 2,912 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Interest Rate Risk. We maintain an investment portfolio of various holdings, types, and maturities. Our primary objective for holding fixed income securities is to achieve an appropriate investment return consistent with preserving principal and managing risk. At any time, a sharp rise in market interest rates could have a material adverse impact on the fair value of our fixed income investment portfolio. Conversely, declines in interest rates, including the impact from lower credit spreads, could have a material adverse impact on interest income for our investment portfolio. Our fixed income investments are held for purposes other than trading. Our fixed income investments were not leveraged as of December 31, 2020. We monitor our interest rate and credit risks, including our credit exposures to specific rating categories and to individual issuers. As of December 31, 2020, 41.5% of our fixed income securities balance consisted of U.S. government and U.S. government agency securities. We believe the overall credit quality of our portfolio is strong.

Refer to Note 7 for information on our recent borrowings under the Term Loan Facility. Borrowings under the Term Loan Facility bear interest at a rate equal to, at our option, (a) LIBOR, adjusted for customary statutory reserves, plus an applicable margin of 1.125% to 1.75% depending on our leverage ratio, or (b) an alternate base rate determined in accordance with the Term Credit Agreement, plus an applicable margin of 0.125% to 0.750% depending on our leverage ratio.

The Term Loan Facility requires us to maintain a leverage ratio financial covenant, calculated as of the last day of each fiscal quarter, of consolidated total indebtedness to consolidated EBITDA. This covenant may result in a higher interest rate on our outstanding principal borrowings on the Term Loan Facility in future periods, depending on the Company's performance. At any time, a sharp rise in market interest rates could have a material adverse impact on the interest payable on outstanding principal borrowings on our Term Loan Facility. We monitor our interest rate and credit risks, which include the effect that the COVID-19 pandemic may have on interest rates on principal borrowings under the Term Loan Facility. As of December 31, 2020, we have not noted any adverse impacts to interest rates that would have a material impact to interest owed on principal borrowings.

Foreign Currency Risk. The majority of our sales and expenses are denominated in U.S. dollars and as a result, we have not experienced significant foreign currency transaction gains and losses to date.

Management believes there have been no material changes to our quantitative and qualitative disclosures about market risk during the three month period ended December 31, 2020, compared to those discussed in our Annual Report on Form 10-K for the year ended September 30, 2020.

Controls and procedures

As filed, 1,534 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) are designed to ensure that required information is recorded, processed, summarized and reported within the required timeframe, as specified in the rules set forth by the Securities Exchange Commission. Our disclosure controls and procedures are also designed to ensure that information required to be disclosed is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2020 and, based on this evaluation, our Chief

Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December 31, 2020.

Changes in Internal Control over Financial Reporting

During the first fiscal quarter, there were no changes to our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Although the entire global F5 workforce is working remotely as a result of the COVID-19 pandemic, there were no material changes to our existing internal controls over financial reporting as a result of this.

Risk factors

As filed, 273 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to our risk factors from those described in Part 1, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, which was filed with the Securities and Exchange Commission on November 19, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-10-01 to 2020-12-31$624.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-10-01 to 2020-12-31$115.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-10-01 to 2020-12-31$509.6mus-gaap:GrossProfit
Research and development3 months2020-10-01 to 2020-12-31$114.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-10-01 to 2020-12-31$117.7mus-gaap:OperatingIncomeLoss
Income tax3 months2020-10-01 to 2020-12-31$29.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-10-01 to 2020-12-31$87.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-10-01 to 2020-12-31$1.41us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-10-01 to 2020-12-31$1.43us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-10-01 to 2020-12-3162,282,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2020-10-01 to 2020-12-31$137.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-10-01 to 2020-12-31$4.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-12-31$1.03bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$2.03bnus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$4.90bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$1.32bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-12-31$364.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-12-31$19.3mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-12-31$2.40bnus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001048695-21-000009. Last ingested by Listed: Nov 10, 2026, 04:33 ET. Listed shows no prices and gives no investment advice.